{"id":"W2947664767","doi":"10.1200/jco.2019.37.15_suppl.4500","title":"Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC): Outcomes in the combined IMDC intermediate/poor risk and sarcomatoid subgroups of the phase 3 KEYNOTE-426 study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Clinical endpoint; Internal medicine; Axitinib; Oncology; Everolimus; Urology; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005247241,0.0004228741,0.002876655,0.0002478006,0.0001081612,0.00002504141,0.0006627148,0.0002655042,0.0001219365],"category_scores_gemma":[0.002958346,0.0002097423,0.001079186,0.0002672973,0.0004363542,0.000120564,0.0001523892,0.001427798,0.00001081751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002479103,"about_ca_system_score_gemma":0.001306216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002076938,"about_ca_topic_score_gemma":0.0002944005,"domain_scores_codex":[0.9927412,0.002090349,0.003481973,0.0004063676,0.00080496,0.0004751597],"domain_scores_gemma":[0.9793314,0.01607692,0.003145359,0.000676565,0.0004683755,0.0003013844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2563241,0.02503675,0.6883807,0.0002383398,0.001796334,0.001296798,0.003757617,0.00005579415,0.0004601596,0.00009469334,0.0007573575,0.02180138],"study_design_scores_gemma":[0.254493,0.1341357,0.6035413,0.00007786424,0.001312648,0.0002760961,0.002584429,0.0003265366,0.0008724089,0.000290492,0.001899444,0.0001901318],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904943,0.0006934351,0.00002239079,0.003865803,0.00131001,0.003074325,0.00004847293,0.000008240547,0.0004830462],"genre_scores_gemma":[0.9974437,0.0005493825,0.0003476376,0.001088867,0.0002766044,0.00006480582,0.00001257285,0.00004797128,0.0001684398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1090989,"threshold_uncertainty_score":0.8553042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1072575345345061,"score_gpt":0.4269286395181067,"score_spread":0.3196711049836006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}